MedTrace Logo

ARENA - Project Atrial Fibrilation Rhine-Neckar Region

NCT02978248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2777

Last updated 2023-04-12

No results posted yet for this study

Summary

ARENA aims to inform patients about the symptoms and the risks of atrial fibrilation.

The study design includes three study arms:

1. ARENA Intervention: This project will examine the effectiveness of population education.
2. ARENA Medication: The aim is to examine the patient's adherence and to analyze whether there are any complications.
3. ARENA Migration: ARENA migration aims to examine whether a targeted population education can improve the care of people with a Turkish migration background.

Conditions

Sponsors & Collaborators

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Martin Borggrefe, Prof. Dr. · Universitätsmedizin Mannheim

  • Walter E. Haefeli, Prof. Dr. · University Hospital Heidelberg

  • Ömer Sanatci, Dr. med. · Praxis Merz Sanatci

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-12-31
Completion
2021-07-19

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02978248 on ClinicalTrials.gov